Literature DB >> 3816546

Effect of warfarin on the activated partial thromboplastin time.

V M Hauser, S L Rozek.   

Abstract

Outpatients followed in an anticoagulation clinic were studied retrospectively to determine the effect of warfarin on the activated partial thromboplastin time (APTT). Twenty-nine patients were studied in part 1 of the trial to determine whether their APTT values were elevated when their prothrombin time (PT) was within 1.5 to 2.5 times the control PT. Part 2 was carried out using the data of 32 patients to determine whether a correlation existed between the degree of elevation of the patients' PT values due to warfarin and the concurrent degree of elevation of their APTT results. Baseline PT and APTT values and a minimum of three concurrent PT and APTT values determined during anticoagulation therapy with warfarin were used. Data were collected by chart review and review of Hematology Department records. Results indicated that a statistically significant difference was evident between the baseline APTT (30.79 sec) and the mean APTT (55.10 sec) when the PT was within the therapeutic range of 1.5 to 2.5 times the control while on warfarin therapy. Good linear correlation was evident (r = 0.821) between the degree of elevation of the PT and the degree of elevation of the APTT for the group. In most cases, a good linear correlation was also evident for individual patients. Routine ordering of concurrent APTT and PT tests for patients receiving warfarin therapy is not needed since the PT alone can be monitored under most circumstances.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816546     DOI: 10.1177/106002808602001210

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  7 in total

1.  Clinical relevance of isolated prolongation of the activated partial thromboplastin time in a cohort of adults undergoing surgical procedures.

Authors:  Giuseppe Tagariello; Paolo Radossi; Roberta Salviato; Milena Zardo; Lucia De Valentin; Marco Basso; Giancarlo Castaman
Journal:  Blood Transfus       Date:  2016-07-22       Impact factor: 3.443

2.  Diffuse alveolar haemorrhage secondary to warfarin therapy for atrial fibrillation: a case report and literature review.

Authors:  Abdelkarim Waness; Tarek Aldabbagh; Mohammed Harakati
Journal:  BMJ Case Rep       Date:  2009-03-17

Review 3.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

Review 4.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

5.  A 75-year-old woman with acquired haemophilia disguised by warfarin treatment.

Authors:  Sarah Lawless; Gary Benson
Journal:  BMJ Case Rep       Date:  2015-10-06

6.  Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy.

Authors:  Carmen Sobrino Jiménez; José Antonio Romero-Garrido; Ángeles García-Martín; Manuel Quintana-Díaz; Carlos Jiménez-Vicente; Luis González-Del Valle; Alicia Herrero Ambrosio; Juana Benedí-González
Journal:  Eur J Hosp Pharm       Date:  2020-06-26

7.  Global assays and the management of oral anticoagulation.

Authors:  Herm Jan M Brinkman
Journal:  Thromb J       Date:  2015-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.